The Methuselah Foundation has launched a new prize to advance life extension and regenerative medicine.
The NewOrgan Prize will be given for successfully constructing a whole new organ – heart, kidney, lung, pancreas or liver – from a patient’s own cells. The organ must be transplanted and have functioned properly for two years in order for the award to be granted. The dollar amount of the prize will grow with donations from the general public.
The newest longevity prize specifically focuses on speeding up the development of replacement tissues and organs for humans. The goal is to accelerate advances in regenerative medicine that will become the standard of care for replacing all tissue and organ systems in the body within 20 years, according to the U.S. Department of Health & Human Services.
The first research team to construct a whole new complex organ (heart, kidney, liver, lung, pancreas) from a person’s own cells and successfully transplant it will be awarded the NewOrgan Prize. Their goal is to achieve this medical breakthrough within the next 10 years.
Based on the success in spurring medical advances with the original Methuselah Mouse prize or Mprize, it anticipated that over $10 million will be raised by the time the NewOrgan Prize criteria is met – and the prize presented – to the leading medical R&D team.
Methuselah Foundation is proud to launch the NewOrgan Network community at My Bridge 4 Life. If you need a replacement organ, you can reach out to friends and family for support – and become part of the vital move to drive scientific progress related to healthy organs via the NewOrgan Prize.
They have already attracted a world class Scientific Advisory Board for this effort, including:
* Anthony Atala, MD – Wake Forest University W.H. Boyce Professor; Director of the Institute for Regenerative Medicine; Chair, Department of Urology
* Stephen F. Badylak, DVM, PhD, MD – University of Pittsburgh Professor, Department of Surgery; Deputy Director McGowan Institute for Regenerative Medicine; Director of the Center for Pre-Clinical Tissue Engineering
* Gabor Forgacs, Ph.D – University of Missouri George H Vineyard Professor of Theoretical Physics; Scientific Founder, Organovo
* Doris Taylor, Ph.D – University of Minnesota Professor of Medicine; Director Center for Cardiovascular Repair; Medtronic Bakken Professor of Integrative Biology and Physiology
In addition to our notable Executive Advisory Board:
Roger Holzberg, Founder & CEO, My Bridge 4 Life and Methuselah Foundation’s CCO/Creative Director
Keith Murphy, CEO & President, Organovo
David Jacobs, Founder & CEO, Silverstone Solutions
Robert Cohen, CEO, Miromatrix